Global Bile Duct Cancer Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bile Duct Cancer Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bile Duct Cancer Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bile Duct Cancer Drug by Country/Region, 2017, 2022 & 2028

2.2 Bile Duct Cancer Drug Segment by Type

2.2.1 Cabozantinib S-malate

2.2.2 Elpamotide

2.2.3 Exatecan Mesylate

2.2.4 LY-2801653

2.2.5 NUC-1031

2.2.6 Others

2.3 Bile Duct Cancer Drug Sales by Type

2.3.1 Global Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Bile Duct Cancer Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bile Duct Cancer Drug Sale Price by Type (2017-2022)

2.4 Bile Duct Cancer Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Bile Duct Cancer Drug Sales by Application

2.5.1 Global Bile Duct Cancer Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Bile Duct Cancer Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bile Duct Cancer Drug Sale Price by Application (2017-2022)

3 Global Bile Duct Cancer Drug by Company

3.1 Global Bile Duct Cancer Drug Breakdown Data by Company

3.1.1 Global Bile Duct Cancer Drug Annual Sales by Company (2020-2022)

3.1.2 Global Bile Duct Cancer Drug Sales Market Share by Company (2020-2022)

3.2 Global Bile Duct Cancer Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Bile Duct Cancer Drug Revenue by Company (2020-2022)

3.2.2 Global Bile Duct Cancer Drug Revenue Market Share by Company (2020-2022)

3.3 Global Bile Duct Cancer Drug Sale Price by Company

3.4 Key Manufacturers Bile Duct Cancer Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bile Duct Cancer Drug Product Location Distribution

3.4.2 Players Bile Duct Cancer Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bile Duct Cancer Drug by Geographic Region

4.1 World Historic Bile Duct Cancer Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Bile Duct Cancer Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bile Duct Cancer Drug Annual Revenue by Geographic Region

4.2 World Historic Bile Duct Cancer Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Bile Duct Cancer Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bile Duct Cancer Drug Annual Revenue by Country/Region

4.3 Americas Bile Duct Cancer Drug Sales Growth

4.4 APAC Bile Duct Cancer Drug Sales Growth

4.5 Europe Bile Duct Cancer Drug Sales Growth

4.6 Middle East & Africa Bile Duct Cancer Drug Sales Growth

5 Americas

5.1 Americas Bile Duct Cancer Drug Sales by Country

5.1.1 Americas Bile Duct Cancer Drug Sales by Country (2017-2022)

5.1.2 Americas Bile Duct Cancer Drug Revenue by Country (2017-2022)

5.2 Americas Bile Duct Cancer Drug Sales by Type

5.3 Americas Bile Duct Cancer Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bile Duct Cancer Drug Sales by Region

6.1.1 APAC Bile Duct Cancer Drug Sales by Region (2017-2022)

6.1.2 APAC Bile Duct Cancer Drug Revenue by Region (2017-2022)

6.2 APAC Bile Duct Cancer Drug Sales by Type

6.3 APAC Bile Duct Cancer Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bile Duct Cancer Drug by Country

7.1.1 Europe Bile Duct Cancer Drug Sales by Country (2017-2022)

7.1.2 Europe Bile Duct Cancer Drug Revenue by Country (2017-2022)

7.2 Europe Bile Duct Cancer Drug Sales by Type

7.3 Europe Bile Duct Cancer Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bile Duct Cancer Drug by Country

8.1.1 Middle East & Africa Bile Duct Cancer Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bile Duct Cancer Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Bile Duct Cancer Drug Sales by Type

8.3 Middle East & Africa Bile Duct Cancer Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bile Duct Cancer Drug

10.3 Manufacturing Process Analysis of Bile Duct Cancer Drug

10.4 Industry Chain Structure of Bile Duct Cancer Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bile Duct Cancer Drug Distributors

11.3 Bile Duct Cancer Drug Customer

12 World Forecast Review for Bile Duct Cancer Drug by Geographic Region

12.1 Global Bile Duct Cancer Drug Market Size Forecast by Region

12.1.1 Global Bile Duct Cancer Drug Forecast by Region (2023-2028)

12.1.2 Global Bile Duct Cancer Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bile Duct Cancer Drug Forecast by Type

12.7 Global Bile Duct Cancer Drug Forecast by Application

13 Key Players Analysis

13.1 Ariad Pharmaceuticals, Inc.

13.1.1 Ariad Pharmaceuticals, Inc. Company Information

13.1.2 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Product Offered

13.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ariad Pharmaceuticals, Inc. Main Business Overview

13.1.5 Ariad Pharmaceuticals, Inc. Latest Developments

13.2 ArQule, Inc.

13.2.1 ArQule, Inc. Company Information

13.2.2 ArQule, Inc. Bile Duct Cancer Drug Product Offered

13.2.3 ArQule, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 ArQule, Inc. Main Business Overview

13.2.5 ArQule, Inc. Latest Developments

13.3 Array BioPharma Inc.

13.3.1 Array BioPharma Inc. Company Information

13.3.2 Array BioPharma Inc. Bile Duct Cancer Drug Product Offered

13.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Array BioPharma Inc. Main Business Overview

13.3.5 Array BioPharma Inc. Latest Developments

13.4 Arrien Pharmaceuticals, LLC

13.4.1 Arrien Pharmaceuticals, LLC Company Information

13.4.2 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product Offered

13.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Arrien Pharmaceuticals, LLC Main Business Overview

13.4.5 Arrien Pharmaceuticals, LLC Latest Developments

13.5 Aslan Pharmaceuticals Pte. Ltd.

13.5.1 Aslan Pharmaceuticals Pte. Ltd. Company Information

13.5.2 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Product Offered

13.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Aslan Pharmaceuticals Pte. Ltd. Main Business Overview

13.5.5 Aslan Pharmaceuticals Pte. Ltd. Latest Developments

13.6 Bavarian Nordic A/S

13.6.1 Bavarian Nordic A/S Company Information

13.6.2 Bavarian Nordic A/S Bile Duct Cancer Drug Product Offered

13.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bavarian Nordic A/S Main Business Overview

13.6.5 Bavarian Nordic A/S Latest Developments

13.7 Bayer AG

13.7.1 Bayer AG Company Information

13.7.2 Bayer AG Bile Duct Cancer Drug Product Offered

13.7.3 Bayer AG Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bayer AG Main Business Overview

13.7.5 Bayer AG Latest Developments

13.8 Blueprint Medicines Corporation

13.8.1 Blueprint Medicines Corporation Company Information

13.8.2 Blueprint Medicines Corporation Bile Duct Cancer Drug Product Offered

13.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Blueprint Medicines Corporation Main Business Overview

13.8.5 Blueprint Medicines Corporation Latest Developments

13.9 Boehringer Ingelheim GmbH

13.9.1 Boehringer Ingelheim GmbH Company Information

13.9.2 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product Offered

13.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Boehringer Ingelheim GmbH Main Business Overview

13.9.5 Boehringer Ingelheim GmbH Latest Developments

13.10 Boston Biomedical, Inc.

13.10.1 Boston Biomedical, Inc. Company Information

13.10.2 Boston Biomedical, Inc. Bile Duct Cancer Drug Product Offered

13.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Boston Biomedical, Inc. Main Business Overview

13.10.5 Boston Biomedical, Inc. Latest Developments

13.11 Bristol-Myers Squibb Company

13.11.1 Bristol-Myers Squibb Company Company Information

13.11.2 Bristol-Myers Squibb Company Bile Duct Cancer Drug Product Offered

13.11.3 Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bristol-Myers Squibb Company Main Business Overview

13.11.5 Bristol-Myers Squibb Company Latest Developments

13.12 Celgene Corporation

13.12.1 Celgene Corporation Company Information

13.12.2 Celgene Corporation Bile Duct Cancer Drug Product Offered

13.12.3 Celgene Corporation Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Celgene Corporation Main Business Overview

13.12.5 Celgene Corporation Latest Developments

13.13 CellAct Pharma GmbH

13.13.1 CellAct Pharma GmbH Company Information

13.13.2 CellAct Pharma GmbH Bile Duct Cancer Drug Product Offered

13.13.3 CellAct Pharma GmbH Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 CellAct Pharma GmbH Main Business Overview

13.13.5 CellAct Pharma GmbH Latest Developments

13.14 Cellceutix Corporation

13.14.1 Cellceutix Corporation Company Information

13.14.2 Cellceutix Corporation Bile Duct Cancer Drug Product Offered

13.14.3 Cellceutix Corporation Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Cellceutix Corporation Main Business Overview

13.14.5 Cellceutix Corporation Latest Developments

13.15 Cellular Biomedicine Group, Inc.

13.15.1 Cellular Biomedicine Group, Inc. Company Information

13.15.2 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Product Offered

13.15.3 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Cellular Biomedicine Group, Inc. Main Business Overview

13.15.5 Cellular Biomedicine Group, Inc. Latest Developments

13.16 Concordia Healthcare Corp.

13.16.1 Concordia Healthcare Corp. Company Information

13.16.2 Concordia Healthcare Corp. Bile Duct Cancer Drug Product Offered

13.16.3 Concordia Healthcare Corp. Bile Duct Cancer Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Concordia Healthcare Corp. Main Business Overview

13.16.5 Concordia Healthcare Corp. Latest Developments

14 Research Findings and Conclusion

Table 1. Bile Duct Cancer Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bile Duct Cancer Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cabozantinib S-malate

Table 4. Major Players of Elpamotide

Table 5. Major Players of Exatecan Mesylate

Table 6. Major Players of LY-2801653

Table 7. Major Players of NUC-1031

Table 8. Major Players of Others

Table 9. Global Bile Duct Cancer Drug Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

Table 11. Global Bile Duct Cancer Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global Bile Duct Cancer Drug Revenue Market Share by Type (2017-2022)

Table 13. Global Bile Duct Cancer Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Bile Duct Cancer Drug Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Table 16. Global Bile Duct Cancer Drug Revenue by Application (2017-2022)

Table 17. Global Bile Duct Cancer Drug Revenue Market Share by Application (2017-2022)

Table 18. Global Bile Duct Cancer Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Bile Duct Cancer Drug Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Bile Duct Cancer Drug Sales Market Share by Company (2020-2022)

Table 21. Global Bile Duct Cancer Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Bile Duct Cancer Drug Revenue Market Share by Company (2020-2022)

Table 23. Global Bile Duct Cancer Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Bile Duct Cancer Drug Producing Area Distribution and Sales Area

Table 25. Players Bile Duct Cancer Drug Products Offered

Table 26. Bile Duct Cancer Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Bile Duct Cancer Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Bile Duct Cancer Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global Bile Duct Cancer Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Bile Duct Cancer Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Bile Duct Cancer Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Bile Duct Cancer Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global Bile Duct Cancer Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Bile Duct Cancer Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Bile Duct Cancer Drug Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Bile Duct Cancer Drug Sales Market Share by Country (2017-2022)

Table 39. Americas Bile Duct Cancer Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Bile Duct Cancer Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas Bile Duct Cancer Drug Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

Table 43. Americas Bile Duct Cancer Drug Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Table 45. APAC Bile Duct Cancer Drug Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Bile Duct Cancer Drug Sales Market Share by Region (2017-2022)

Table 47. APAC Bile Duct Cancer Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Bile Duct Cancer Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC Bile Duct Cancer Drug Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

Table 51. APAC Bile Duct Cancer Drug Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Table 53. Europe Bile Duct Cancer Drug Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Bile Duct Cancer Drug Sales Market Share by Country (2017-2022)

Table 55. Europe Bile Duct Cancer Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Bile Duct Cancer Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe Bile Duct Cancer Drug Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

Table 59. Europe Bile Duct Cancer Drug Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Bile Duct Cancer Drug Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Bile Duct Cancer Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Bile Duct Cancer Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Bile Duct Cancer Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Bile Duct Cancer Drug Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Bile Duct Cancer Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Bile Duct Cancer Drug Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Bile Duct Cancer Drug

Table 70. Key Market Challenges & Risks of Bile Duct Cancer Drug

Table 71. Key Industry Trends of Bile Duct Cancer Drug

Table 72. Bile Duct Cancer Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Bile Duct Cancer Drug Distributors List

Table 75. Bile Duct Cancer Drug Customer List

Table 76. Global Bile Duct Cancer Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Bile Duct Cancer Drug Sales Market Forecast by Region

Table 78. Global Bile Duct Cancer Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Bile Duct Cancer Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Bile Duct Cancer Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Bile Duct Cancer Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Bile Duct Cancer Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Bile Duct Cancer Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Bile Duct Cancer Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Bile Duct Cancer Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Bile Duct Cancer Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Bile Duct Cancer Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Bile Duct Cancer Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Bile Duct Cancer Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Bile Duct Cancer Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Bile Duct Cancer Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Bile Duct Cancer Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Bile Duct Cancer Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Bile Duct Cancer Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Bile Duct Cancer Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. Ariad Pharmaceuticals, Inc. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Product Offered

Table 98. Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Ariad Pharmaceuticals, Inc. Main Business

Table 100. Ariad Pharmaceuticals, Inc. Latest Developments

Table 101. ArQule, Inc. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. ArQule, Inc. Bile Duct Cancer Drug Product Offered

Table 103. ArQule, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. ArQule, Inc. Main Business

Table 105. ArQule, Inc. Latest Developments

Table 106. Array BioPharma Inc. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Array BioPharma Inc. Bile Duct Cancer Drug Product Offered

Table 108. Array BioPharma Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Array BioPharma Inc. Main Business

Table 110. Array BioPharma Inc. Latest Developments

Table 111. Arrien Pharmaceuticals, LLC Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product Offered

Table 113. Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Arrien Pharmaceuticals, LLC Main Business

Table 115. Arrien Pharmaceuticals, LLC Latest Developments

Table 116. Aslan Pharmaceuticals Pte. Ltd. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Product Offered

Table 118. Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Aslan Pharmaceuticals Pte. Ltd. Main Business

Table 120. Aslan Pharmaceuticals Pte. Ltd. Latest Developments

Table 121. Bavarian Nordic A/S Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Bavarian Nordic A/S Bile Duct Cancer Drug Product Offered

Table 123. Bavarian Nordic A/S Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Bavarian Nordic A/S Main Business

Table 125. Bavarian Nordic A/S Latest Developments

Table 126. Bayer AG Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. Bayer AG Bile Duct Cancer Drug Product Offered

Table 128. Bayer AG Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Bayer AG Main Business

Table 130. Bayer AG Latest Developments

Table 131. Blueprint Medicines Corporation Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. Blueprint Medicines Corporation Bile Duct Cancer Drug Product Offered

Table 133. Blueprint Medicines Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Blueprint Medicines Corporation Main Business

Table 135. Blueprint Medicines Corporation Latest Developments

Table 136. Boehringer Ingelheim GmbH Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product Offered

Table 138. Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Boehringer Ingelheim GmbH Main Business

Table 140. Boehringer Ingelheim GmbH Latest Developments

Table 141. Boston Biomedical, Inc. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Boston Biomedical, Inc. Bile Duct Cancer Drug Product Offered

Table 143. Boston Biomedical, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Boston Biomedical, Inc. Main Business

Table 145. Boston Biomedical, Inc. Latest Developments

Table 146. Bristol-Myers Squibb Company Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 147. Bristol-Myers Squibb Company Bile Duct Cancer Drug Product Offered

Table 148. Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Bristol-Myers Squibb Company Main Business

Table 150. Bristol-Myers Squibb Company Latest Developments

Table 151. Celgene Corporation Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 152. Celgene Corporation Bile Duct Cancer Drug Product Offered

Table 153. Celgene Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Celgene Corporation Main Business

Table 155. Celgene Corporation Latest Developments

Table 156. CellAct Pharma GmbH Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 157. CellAct Pharma GmbH Bile Duct Cancer Drug Product Offered

Table 158. CellAct Pharma GmbH Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. CellAct Pharma GmbH Main Business

Table 160. CellAct Pharma GmbH Latest Developments

Table 161. Cellceutix Corporation Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 162. Cellceutix Corporation Bile Duct Cancer Drug Product Offered

Table 163. Cellceutix Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 164. Cellceutix Corporation Main Business

Table 165. Cellceutix Corporation Latest Developments

Table 166. Cellular Biomedicine Group, Inc. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 167. Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Product Offered

Table 168. Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 169. Cellular Biomedicine Group, Inc. Main Business

Table 170. Cellular Biomedicine Group, Inc. Latest Developments

Table 171. Concordia Healthcare Corp. Basic Information, Bile Duct Cancer Drug Manufacturing Base, Sales Area and Its Competitors

Table 172. Concordia Healthcare Corp. Bile Duct Cancer Drug Product Offered

Table 173. Concordia Healthcare Corp. Bile Duct Cancer Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 174. Concordia Healthcare Corp. Main Business

Table 175. Concordia Healthcare Corp. Latest Developments

List of Figures

Figure 1. Picture of Bile Duct Cancer Drug

Figure 2. Bile Duct Cancer Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bile Duct Cancer Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Bile Duct Cancer Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bile Duct Cancer Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cabozantinib S-malate

Figure 10. Product Picture of Elpamotide

Figure 11. Product Picture of Exatecan Mesylate

Figure 12. Product Picture of LY-2801653

Figure 13. Product Picture of NUC-1031

Figure 14. Product Picture of Others

Figure 15. Global Bile Duct Cancer Drug Sales Market Share by Type in 2021

Figure 16. Global Bile Duct Cancer Drug Revenue Market Share by Type (2017-2022)

Figure 17. Bile Duct Cancer Drug Consumed in Hospital

Figure 18. Global Bile Duct Cancer Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 19. Bile Duct Cancer Drug Consumed in Clinic

Figure 20. Global Bile Duct Cancer Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 21. Bile Duct Cancer Drug Consumed in Others

Figure 22. Global Bile Duct Cancer Drug Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Bile Duct Cancer Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Bile Duct Cancer Drug Revenue Market Share by Application in 2021

Figure 25. Bile Duct Cancer Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Bile Duct Cancer Drug Revenue Market Share by Company in 2021

Figure 27. Global Bile Duct Cancer Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Bile Duct Cancer Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Bile Duct Cancer Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Bile Duct Cancer Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Bile Duct Cancer Drug Sales 2017-2022 (K Pcs)

Figure 32. Americas Bile Duct Cancer Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Bile Duct Cancer Drug Sales 2017-2022 (K Pcs)

Figure 34. APAC Bile Duct Cancer Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Bile Duct Cancer Drug Sales 2017-2022 (K Pcs)

Figure 36. Europe Bile Duct Cancer Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Bile Duct Cancer Drug Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Bile Duct Cancer Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Bile Duct Cancer Drug Sales Market Share by Country in 2021

Figure 40. Americas Bile Duct Cancer Drug Revenue Market Share by Country in 2021

Figure 41. United States Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Bile Duct Cancer Drug Sales Market Share by Region in 2021

Figure 46. APAC Bile Duct Cancer Drug Revenue Market Share by Regions in 2021

Figure 47. China Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Bile Duct Cancer Drug Sales Market Share by Country in 2021

Figure 54. Europe Bile Duct Cancer Drug Revenue Market Share by Country in 2021

Figure 55. Germany Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Bile Duct Cancer Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Bile Duct Cancer Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Bile Duct Cancer Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Bile Duct Cancer Drug in 2021

Figure 68. Manufacturing Process Analysis of Bile Duct Cancer Drug

Figure 69. Industry Chain Structure of Bile Duct Cancer Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles